According to the latest report by IMARC Group, titled “Cochlear Implants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, the global cochlear implants market reached a value of US$ 2.1 Billion in 2022. A cochlear implant is a small, complex electronic device that provides a sense of sound to a person who has average or profound hearing loss. It is surgically implanted and works by electrically stimulating the cochlear nerve and transforming sound vibrations into signals. These signals are further sent to the brain as recognizable sounds for understanding speech. A cochlear implant comprises a microphone, transmitter, speech processor and an electrode array. It does not rectify or treat the cause of hearing impotency but works as a prosthetic substitute to provide a representation of environmental sounds.
Global Cochlear Implants Market Trends:
The growing geriatric population, in confluence with the increasing number of children who are born with hearing defects, represents one of the significant factors impelling the market growth. Besides this, the rising awareness about the benefits of hearing aids is also boosting the overall sales of these implants. Furthermore, leading manufacturers are introducing user-friendly and efficient product variants in the market. For instance, they are launching rechargeable cochlear implants that are integrated with next-generation sound processors. In addition to this, government and non-governmental organizations (NGOs) are focusing on improving access to quality healthcare facilities to all. On account of these factors, the market value is projected to reach US$ 3.5 Billion by 2028, exhibiting a CAGR of 9.1% during 2023-2028.
- Based on the implant type, the market has been bifurcated into unilateral and bilateral cochlear implants. At present, unilateral cochlear implants represent the most popular product type that exhibits a clear dominance in the market. These implants are mainly used by individuals who suffer from unilateral hearing disorder, which reduces their ability to localize sounds.
- On the basis of the end-user, the market has been divided into adults and children. Adults currently account for the majority of the total market share, owing to the significant increase in aging population.
- Region-wise, Europe represents the largest market. Other major markets include Asia Pacific, North America, Middle East and Africa, and Latin America.
- The competitive landscape of the market has been examined with some of the key players being Cochlear Ltd., MED-EL, Advanced Bionics Corporation, William Demant, Nurotron Biotechnology Ltd., Oticon Medical and Sonova AG.
|Base Year of the Analysis
||Implant Type, End-User, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||Cochlear Ltd., MED-EL, Advanced Bionics Corporation, William Demant, Nurotron Biotechnology Ltd., Oticon Medical, and Sonova
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Follow us on twitter: @imarcglobal